YD Bio Ltd (YDES)Healthcare | Biotechnology | Taipei, Taiwan | NasdaqGM
2.15 USD
-0.08
(-3.587%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 1.99 -0.16 (-0.160%) ⇩ (July 13, 2026, 7:35 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 3:45 a.m. EDT
The immediate outlook is severely clouded by a brutal recent price collapse, with the stock tumbling from highs near $2.80 to lows around $1.90 over the last two weeks, signaling intense selling pressure and a loss of technical support. While the company boasts an impressive 95.6% revenue growth and a massive cash reserve relative to its tiny market cap, these bright spots are currently overshadowed by deep operational losses, negative free cash flow, and a valuation metric that is mathematically impossible to interpret due to zero earnings. The absence of any dividend history confirms this is a pure speculative growth play with no income floor. For the long term, the business appears to be in a fragile early-stage phase where the path to profitability remains unclear, preventing a higher rating despite the top-line expansion. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.210940 |
| AutoARIMA | 0.427982 |
| AutoETS | 0.427990 |
| MSTL | 0.448254 |
Forecast horizon: 60 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 26% |
| H-stat | 111.73 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.066 |
| Excess Kurtosis | -1.23 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.338 |
| Revenue per Share | 0.466 |
| Market Cap | 152,287,392 |
| Beta | -0.13 |
| Profit Margins | -276.58% |
| Previous Name | Breeze Holdings Acquisition Corp. |
| Website | https://www.ydesgroup.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.83308387 |
| Address1 | No. 3, Xingnan St. |
| Address2 | 12F. Nangang Dist. |
| All Time High | 25.0 |
| All Time Low | 1.7 |
| Ask | 2.49 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 611,490 |
| Average Daily Volume3 Month | 129,000 |
| Average Volume | 129,000 |
| Average Volume10Days | 611,490 |
| Beta | -0.127 |
| Bid | 2.06 |
| Bid Size | 1 |
| Book Value | 4.571 |
| City | Taipei |
| Country | Taiwan |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.15 |
| Current Ratio | 13.183 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 2.22 |
| Day Low | 2.0005 |
| Debt To Equity | 0.338 |
| Display Name | YD Bio |
| Ebitda | -1,357,195 |
| Ebitda Margins | -2.6592898 |
| Enterprise To Ebitda | 0.008 |
| Enterprise To Revenue | -0.02 |
| Enterprise Value | -10,236 |
| Eps Trailing Twelve Months | -0.12 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.6142 |
| Fifty Day Average Change | -1.4642 |
| Fifty Day Average Change Percent | -0.40512422 |
| Fifty Two Week Change Percent | -83.30839 |
| Fifty Two Week High | 25.0 |
| Fifty Two Week High Change | -22.85 |
| Fifty Two Week High Change Percent | -0.91400003 |
| Fifty Two Week Low | 1.7 |
| Fifty Two Week Low Change | 0.45000005 |
| Fifty Two Week Low Change Percent | 0.2647059 |
| Fifty Two Week Range | 1.7 - 25.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,756,215,000,000 |
| Float Shares | 319,740 |
| Free Cashflow | -3,875,569 |
| Full Exchange Name | NasdaqGM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.3044 |
| Gross Profits | 155,356 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.80132 |
| Held Percent Institutions | 0.00225 |
| Implied Shares Outstanding | 70,831,346 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-08-29 |
| Language | en-US |
| Last Fiscal Year End | 1,735,603,200 |
| Long Business Summary | YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan. |
| Long Name | YD Bio Ltd |
| Market | us_market |
| Market Cap | 152,287,392 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1898493574 |
| Most Recent Quarter | 1,735,603,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -1,411,559 |
| Next Fiscal Year End | 1,767,139,200 |
| Non Diluted Market Cap | 157,953,901 |
| Open | 2.15 |
| Operating Cashflow | -1,836,818 |
| Operating Margins | -4.44588 |
| Payout Ratio | 0.0 |
| Post Market Change | -0.16000009 |
| Post Market Change Percent | -7.4418635 |
| Post Market Price | 1.99 |
| Post Market Time | 1,783,985,738 |
| Prev Name | Breeze Holdings Acquisition Corp. |
| Previous Close | 2.23 |
| Price Hint | 4 |
| Price To Book | 0.4703566 |
| Price To Sales Trailing12 Months | 298.3921 |
| Profit Margins | -2.76581 |
| Quick Ratio | 12.906 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0799999 |
| Regular Market Change Percent | -3.58744 |
| Regular Market Day High | 2.22 |
| Regular Market Day Low | 2.0005 |
| Regular Market Day Range | 2.0005 - 2.22 |
| Regular Market Open | 2.15 |
| Regular Market Previous Close | 2.23 |
| Regular Market Price | 2.15 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 62,674 |
| Return On Assets | -0.25432 |
| Return On Equity | -0.42689 |
| Revenue Growth | 0.956 |
| Revenue Per Share | 0.466 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 70,831,346 |
| Shares Percent Shares Out | 0.0002 |
| Shares Short | 11,169 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 16,646 |
| Short Name | YD Bio Limited |
| Short Percent Of Float | 0.0007 |
| Short Ratio | 0.18 |
| Source Interval | 15 |
| Symbol | YDES |
| Total Cash | 3,132,298 |
| Total Cash Per Share | 2.173 |
| Total Debt | 22,265 |
| Total Revenue | 510,360 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.12 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 9.2539 |
| Two Hundred Day Average Change | -7.1038995 |
| Two Hundred Day Average Change Percent | -0.7676655 |
| Type Disp | Equity |
| Volume | 62,674 |
| Website | https://www.ydesgroup.com |
| Zip | 115,001 |